Abpro Holdings receives Nasdaq minimum bid price deficiency notice; 180-day cure period.

Abpro Holdings, Inc.

Received Nasdaq notice on April 2, 2025, for failure to meet $1.00 minimum bid price requirement.
Closing bid price below $1.00 for 30 consecutive business days triggers the deficiency.
Company has 180 calendar days, until September 29, 2025, to regain compliance.
To regain compliance, common stock must close at $1.00+ for 10 consecutive business days.
If not cured by Sept 29, may qualify for an additional 180-day compliance period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.